The only international event dedicated to discussing regulatory, ethical and operational aspects of running clinical trials in Russia

30 November - 1 December 2021

Moscow, Russia, Intercontinental Hotel

Speakers in 2021

Dmitry Rozhdestvensky, Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation, Eurasian Economic Commission
Dmitry Rozhdestvensky

Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation

Eurasian Economic Commission

Elena Khvostikova, Director, “Genome” Patient Support Centre
Elena Khvostikova

Director

“Genome” Patient Support Centre

Alina Mustafina, Medical devices department lector, RMANPO
Alina Mustafina

Medical devices department lector

RMANPO

Maria Leer, Head of Medical Projects Group, Takeda
Maria Leer

Head of Medical Projects Group

Takeda

Almira Galeeva, Director of Clinical Research & Medical Affairs, AIPM Russia
Almira Galeeva

Director of Clinical Research & Medical Affairs

AIPM Russia

Olga Melnik, Head of Clinical Operations, Novartis Pharma
Olga Melnik

Head of Clinical Operations

Novartis Pharma

Vladimir Andrianov, Head of department of clinical trials, Sechenov University
Vladimir Andrianov

Head of department of clinical trials

Sechenov University

Artem Poltoratskiy, Head of the Department for Pre-Clinical and Clinical Trials, National Medical Research Centre of Oncology Named after N.N.Petrov
Artem Poltoratskiy

Head of the Department for Pre-Clinical and Clinical Trials

National Medical Research Centre of Oncology Named after N.N.Petrov

Irina Efremova,  Head , Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise
Irina Efremova

Head

Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise "Center for Examinations and Tests in Health Service"

KEY TOPICS & FEATURES IN 2020:

o   The current status of the clinical trials market: what are the latest trends in Russia and globally?

o   Clinical trials during the Covid-19 pandemic: practical experiences, challenges and solutions found

o   Clinical trials in the Eurasian Union - registration practices and common rules in action

o   Acceleration of digitalisation in clinical trials: AI, remote monitoring, electronic registers, access to data and data safety

o   RWE - globally and in Russia: RWE as a key tool for the federal project “Digital technologies”

o   Live Interviews with sponsors and research & investigators centres

 

Why attend the Clinical Trials in Russia Forum 2021?

adamsmith 14october2018 049

Insights from 40+ experts: regulators, representatives of international and Russian pharmaceutical producers, CROs and investigators

adamsmith 13october2018 206

2-day information-rich programme that includes insightful presentations from leading sector players, interactive debates and round tables

adamsmith 13october2018 086

Unrivalled networking opportunities with 150+ attendees from such companies as AstraZeneca, Pfizer, Novartis, Bayer, Biocad, R-Pharm and many more

FEEDBACK FROM ATTENDEES

Unique opportunity for all the clinical trials sector players to meet and discuss the most burning issues.

Tatiana Minakova,

Associate Director, Clinical Monitoring, Syneos Health

The forum brings together representatives of all stakeholder groups involved in clinical trials – sponsors, CROs, regulators and investigators for a constructive dialogue aimed at improving all future processes.

Julia Semenova,

Pharma Development Unit Head, Novartis Russia

Very good overview of a large number of clinical trial topics and the specifics of the Russian market.

Henryette Schatt,

JDirector eCOA Business Development, ERT (Switzerland)

Very interesting insight into the latest developments in the Russian market.

Stefanie Rau,

Clinical Trials and Pharmacovigilance Manager Europe, MUCOS Pharma (Germany)


Sponsored by:

Supporting organisations & media